Literature DB >> 965036

Enzymic and immunochemical properties of lysozyme--XV. Delineation of the reactive site around the two central disulfides by immunochemical studies of novel synthetic peptides that contain diglycyl bridges instead of disulfides.

C L Lee, R C Pai, M Z Atassi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 965036     DOI： 10.1016/0019-2791(76)90209-3

Source DB:  PubMed          Journal:  Immunochemistry        ISSN： 0019-2791


× No keyword cloud information.
  6 in total

1.  Antigenic structure of human haemoglobin. Localization of the antigenic sites of the beta-chain in three host species by synthetic overlapping peptides representing the entire chain.

Authors:  N Yoshioka; M Z Atassi
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

2.  Structurally inherent antigenic sites. Localization of the antigenic sites of the alpha-chain of human haemoglobin in three host species by a comprehensive synthetic approach.

Authors:  A L Kazim; M Z Atassi
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

3.  Localization and verification by synthesis of five antigenic sites of bovine serum albumin.

Authors:  M Z Atassi; S Sakata; A L Kazim
Journal:  Biochem J       Date:  1979-05-01       Impact factor: 3.857

4.  Boundary refinement of the lysozyme antigenic site around the disulphide bond 6-127 (site 1) by 'surface-simulation' synthesis.

Authors:  M Z Atassi; C L Lee
Journal:  Biochem J       Date:  1978-05-01       Impact factor: 3.857

5.  Enzymic and immunochemical properties of lysozyme. Accurate definition of the antigenic site around the disulphide bridge 30-115 (site 3) by 'surface-simulation' synthesis.

Authors:  C L Lee; M Z Atassi
Journal:  Biochem J       Date:  1977-12-01       Impact factor: 3.857

6.  SUPERFICIAL--surface mapping of proteins via structure-based peptide library design.

Authors:  Andrean Goede; Ines S Jaeger; Robert Preissner
Journal:  BMC Bioinformatics       Date:  2005-09-09       Impact factor: 3.169
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.